Impact of Influenza and Pneumococcal Vaccines on HIV Persistence and Immune Dynamics during Suppressive Antiretroviral Therapy

0
34
Persons with HIV on antiretroviral therapy were enrolled in the clinical trial. Blood was collected at baseline and days 2,4,7,14 and 30 postimmunizations. Expression of immunological markers on T cell subsets were measured by flow cytometry.
[Aids]
Abstract